# ANti-Oxidant in Variant Angina (ANOVA) Trial

> **NCT03228238** · PHASE4 · TERMINATED · sponsor: **Seoul National University Hospital** · enrollment: 320 (actual)

## Conditions studied

- Variant Angina

## Interventions

- **DRUG:** Vitamin C and Vitamin E
- **DRUG:** Statin
- **DRUG:** Standard medication for variant angina

## Key facts

- **NCT ID:** NCT03228238
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 320 (ACTUAL)
- **Why stopped:** The study was terminated early due to slow recruitment and the Principal Investigator's retirement.
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03228238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03228238, "ANti-Oxidant in Variant Angina (ANOVA) Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03228238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*